Sort   by:  
 Page size 
UnknownSafety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Not available
S-EPMC6436835 | biostudies-literature
UnknownPractices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey.
Not available
S-EPMC9260059 | biostudies-literature
UnknownA SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study.
Not available
S-EPMC8478961 | biostudies-literature
UnknownVirologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Not available
S-EPMC12366723 | biostudies-literature
UnknownClinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics: A Randomized Clinical Trial.
Not available
S-EPMC12949440 | biostudies-literature
UnknownPrior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
Not available
S-EPMC5709580 | biostudies-literature
UnknownDNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
Not available
S-EPMC6214651 | biostudies-literature
UnknownCutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.
Not available
S-EPMC6287102 | biostudies-literature
UnknownEvaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
Not available
S-EPMC7449230 | biostudies-literature
UnknownFunctional interrogation and mining of natively paired human VH:VL antibody repertoires.
Not available
S-EPMC5801115 | biostudies-literature
Sort   by:  
 Page size